Loading...
Temozolomide promotes immune escape of GBM cells via upregulating PD-L1
Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor with poor prognosis, and currently effective therapeutic strategies are still limited. Although temozolomide (TMZ) is commonly used for GBM therapy and its mechanism was well characterized, while its side effects were req...
Na minha lista:
| Udgivet i: | Am J Cancer Res |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
e-Century Publishing Corporation
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6610056/ https://ncbi.nlm.nih.gov/pubmed/31285949 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|